Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 14
Original Research
Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,128 | Dovepress* | 3,748+ | 178 | 3,926 | |
| PubMed Central* | 380 | 190 | 570 | ||
| Totals | 4,128 | 368 | 4,496 | ||
| *Since 9 December 2022 | |||||
View citations on PubMed Central and Google Scholar